First Time Loading...
I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.37 USD -2.84% Market Closed
Updated: Jun 9, 2024

Immuneering Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immuneering Corp
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
I
Immuneering Corp
NASDAQ:IMRX
Capital Expenditures
-$342.8k
CAGR 3-Years
-90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$795m
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$581m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
-6%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$998m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$464.7m
CAGR 3-Years
-14%
CAGR 5-Years
-41%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$809.1m
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
-15%

See Also

What is Immuneering Corp's Capital Expenditures?
Capital Expenditures
-342.8k USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Capital Expenditures amounts to -342.8k USD.

What is Immuneering Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-90%

Over the last year, the Capital Expenditures growth was 54%. The average annual Capital Expenditures growth rates for Immuneering Corp have been -90% over the past three years .